Acima Private Wealth’s Edwards Lifesciences EW Stock Holding History

Acima Private Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534K	Hold	5,904	–	–	0.16%	74
2026 Q1	$473K	Hold	5,904	–	–	0.15%	75
2025 Q4	$503K	Hold	5,904	–	–	0.16%	74
2025 Q3	$459K	Hold	5,904	–	–	0.14%	76
2025 Q2	$462K	Hold	5,904	–	–	0.16%	74
2025 Q1	$428K	Hold	5,904	–	–	0.15%	77
2024 Q4	$437K	Hold	5,904	–	–	0.15%	82
2024 Q3	$390K	Hold	5,904	–	–	0.13%	90
2024 Q2	$545K	Hold	5,904	–	–	0.2%	72
2024 Q1	$564K	Hold	5,904	–	–	0.21%	76
2023 Q4	$450K	Hold	5,904	–	–	0.18%	85
2023 Q3	$409K	Hold	5,904	–	–	0.18%	93
2023 Q2	$557K	Sell	5,904 -162	-3%	-$14.1K	0.27%	78
2023 Q1	$502K	Hold	6,066	–	–	0.25%	81
2022 Q4	$453K	Hold	6,066	–	–	0.23%	83
2022 Q3	$501K	Hold	6,066	–	–	0.26%	71
2022 Q2	$577K	Hold	6,066	–	–	0.29%	68
2022 Q1	$714K	Hold	6,066	–	–	0.33%	69
2021 Q4	$786K	Hold	6,066	–	–	0.34%	71
2021 Q3	$687K	Hold	6,066	–	–	0.32%	74
2021 Q2	$628K	Hold	6,066	–	–	0.29%	76
2021 Q1	$507K	Hold	6,066	–	–	0.25%	78
2020 Q4	$553K	Hold	6,066	–	–	0.29%	77
2020 Q3	$484K	Hold	6,066	–	–	0.29%	78
2020 Q2	$419K	Hold	6,066	–	–	0.27%	79
2020 Q1	$381K	Hold	6,066	–	–	0.29%	78
2019 Q4	$472K	Hold	6,066	–	–	0.33%	75
2019 Q3	$444K	Hold	6,066	–	–	0.34%	72
2019 Q2	$374K	Hold	6,066	–	–	0.3%	78
2019 Q1	$387K	Hold	6,066	–	–	0.33%	71
2018 Q4	$310K	Buy	+6,066	New	+$307K	0.3%	78

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Acima Private Wealth's EW Position: Q2 2026 in Review

Acima Private Wealth held its Edwards Lifesciences (EW) position steady in Q2 2026 at 5,904 shares worth $534K. The position accounts for 0.16% of the portfolio, ranked #74.

Acima Private Wealth first reported a position in EW in Q4 2018 and has held it in 31 quarters since. The position peaked at $786K in Q4 2021. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Acima Private Wealth held 5,904 shares of Edwards Lifesciences worth $534K as of Q2 2026.
Acima Private Wealth left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.16% of Acima Private Wealth's portfolio in Q2 2026, its #74 holding.
Acima Private Wealth first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 31 quarters since.
Acima Private Wealth's Edwards Lifesciences position peaked at $786K in Q4 2021.
1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Acima Private Wealth's 13F filing for Q2 2026, filed 6 Jul 2026.